Precision AQ
Kyle SanataroVice President
Kyle Sarnataro has over a decade of experience advising pharmaceutical and biotechnology companies on pricing, market access, and commercialization strategy. His work spans the product lifecycle from early development through loss of exclusivity, with deep expertise in early valuation, launch pricing and contracting strategy, competitive simulations, lifecycle management, and value story development and optimization. Kyle supports access for innovative therapies across oncology, immunology, rare disease, and other complex specialty areas—including modalities with unique site‑of‑care, reimbursement, and operational considerations. Known for his analytical rigor and strategic insight, he is frequently sought out by clients and colleagues to help solve complex commercialization challenges.
Insights from Kyle Sanataro
Commercialization & Access | Industry Brief
Innovation and Challenges in Cell & Gene Therapy
Commercialization & Access | White Paper
Challenges and Opportunities for Radiopharmaceutical Commercialization